CLINICAL_TRIALS ClinicalTrials.gov record update

RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors, an Open-label Single-center Phase I Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06545201
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:18.520051+00:00
Published At: 2024-08-09T00:00:00+00:00
Record Updated At: 2024-08-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["KRAS G12V", "T Cell Therapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-08-09"
protocolSection.identificationModule.nctId: "NCT06545201"
protocolSection.identificationModule.officialTitle: "RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors, an Open-label Single-center Phase I Clinical Trial"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.